Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Chemical logic of MraY inhibition by antibacterial nucleoside natural products.

Mashalidis EH, Kaeser B, Terasawa Y, Katsuyama A, Kwon DY, Lee K, Hong J, Ichikawa S, Lee SY.

Nat Commun. 2019 Jul 2;10(1):2917. doi: 10.1038/s41467-019-10957-9.

2.

Homophilic and Heterophilic Interactions of Type II Cadherins Identify Specificity Groups Underlying Cell-Adhesive Behavior.

Brasch J, Katsamba PS, Harrison OJ, Ahlsén G, Troyanovsky RB, Indra I, Kaczynska A, Kaeser B, Troyanovsky S, Honig B, Shapiro L.

Cell Rep. 2018 May 8;23(6):1840-1852. doi: 10.1016/j.celrep.2018.04.012.

3.

GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.

Yoo J, Mashalidis EH, Kuk ACY, Yamamoto K, Kaeser B, Ichikawa S, Lee SY.

Nat Struct Mol Biol. 2018 Mar;25(3):217-224. doi: 10.1038/s41594-018-0031-y. Epub 2018 Feb 19.

4.

Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.

Schmitt C, Kaeser B, Riek M, Bech N, Kreuzer C.

Int J Clin Pharmacol Ther. 2010 Mar;48(3):192-9.

PMID:
20197013
5.

Drug-drug interaction study of ketoconazole and ritonavir-boosted saquinavir.

Kaeser B, Zandt H, Bour F, Zwanziger E, Schmitt C, Zhang X.

Antimicrob Agents Chemother. 2009 Feb;53(2):609-14. doi: 10.1128/AAC.00769-08. Epub 2008 Nov 17.

6.

Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.

Jhee SS, Yen M, Ereshefsky L, Leibowitz M, Schulte M, Kaeser B, Boak L, Patel A, Hoffmann G, Prinssen EP, Rayner CR.

Antimicrob Agents Chemother. 2008 Oct;52(10):3687-93. doi: 10.1128/AAC.00327-08. Epub 2008 Aug 1.

7.

Assessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects.

Kaeser B, Charoin JE, Gerber M, Oxley P, Birnboeck H, Saiedabadi N, Banken L.

Int J Clin Pharmacol Ther. 2005 Mar;43(3):154-62.

PMID:
15792400
8.

Limited effect of food composition on the pharmacokinetics of nelfinavir administered twice daily.

Kurowski M, Kaeser B, Sawyer A, Popescu M, Mroziekiewicz A, Arslan A, Staszewski S.

Eur J Med Res. 2002 Oct 29;7(10):453-6.

PMID:
12435624
9.

Low-dose ritonavir moderately enhances nelfinavir exposure.

Kurowski M, Kaeser B, Sawyer A, Popescu M, Mrozikiewicz A.

Clin Pharmacol Ther. 2002 Aug;72(2):123-32.

PMID:
12189359

Supplemental Content

Loading ...
Support Center